¸Þµð¾÷

³ë¿ø¿¬¼¼Çϳª·ÎÀ̺ñÀÎÈÄ°úÀÇ¿ø °æÀϽŰæ°ú ½ÅÀå ¹°¸®Ä¡·á ÀÇÇпë¾î »ç¶û¾à±¹ ½Å°æÁ¤½Å°ú ÇÑÁø±ÔÄ¡°úÀÇ¿ø ºñ¹ý ºÒ¸éÁõ Åëdz ¿À¶óŬÇǺΰúÀÇ¿ø ¿Ü°ú »ï¼ºÀ¯ ½Å°æ°úÁ¾±Ù´ç¾ÆÄ«º¸ÁîÁ¤ ¹Ð¸®±×¶÷ Á¦¹Ì±Û·ÎÁ¤ ¹Ð¸®±×·¥ ÁßÈ­»êµ¿ °¡ º¸³ªµå·ÐÁ¤ ¹Ð¸®±×·¥ À¯ÇÑÅäºê¶ó¸¶À̽ÅÁÖ»ç¾× ¹Ð¸®±×¶÷
´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
"IPO"¿¡ ´ëÇÑ °Ë»ö °á°ú
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
Ä¿¹Â´ÏƼ - °Ç°­Á¤º¸ (1°Ç)
ºñ¸¸Áõ(ÝþØ»ñø, adipositas)Àº  2014.09.25
ºñ¸¸Áõ(ÝþØ»ñø, adipositas)Àº »ç¶÷ÀÇ ¸ö¹«°Ô°¡ Áö³ªÄ¡°Ô ³ª°¡´Â °ÍÀ» ÅëƲ¾î ºÎ¸£´Â ³¹¸»·Î¼­ º´¸®ÇÐÀûÀ¸·Î´Â ¼¼°è º¸°Ç ±â±¸ ( ..
Ä¿¹Â´ÏƼ - Áúº´Á¤º¸ (5°Ç)
°¡Á·¼º ÀÌ»óº£Å¸Áö´Ü¹éÇ÷Áõ(Familial Dysbetalipoproteinemia)  2015.01.02
¥°.°³¿ä °¡Á·¼º ÀÌ»óº£Å¸Áö´Ü¹éÇ÷ÁõÀº ÄÝ·¹½ºÅ×·Ñ°ú Áß¼ºÁö¹æÀÌ ÇÔ²² Ç÷Áß¿¡ Áõ°¡ÇÏ´Â »ó¿°»öü ¿­¼º À¯Àü¼º ÁúȯÀÔ ..
°¡Á·¼º ÁöÁú´Ü¹é ÁöÁúºÐÇØÈ¿¼Ò °áÇÌÁõ(Familial lipoprotein lipase deficiency)  2015.01.02
±ÂÆĽºÃÄÁõÈıº ¥°. °³¿ä ±ÂÆĽºÃÄÁõÈıº(Goodpastures syndrome)Àº ÆóÃâÇ÷°ú »ç±¸Ã¼½Å¿°ÀÌ µ¿¹ÝµÇ´Â °æ¿ì¸¦ ..
Àúº£Å¸Áö´Ü¹éÇ÷Áõ(Hypobetalipoproteinemia)  2015.01.02
ÁúȯÁÖ¿äÁ¤º¸ °ü·ÃÁúȯ¸í : ¾øÀ½ ¿µÇâºÎÀ§ : ü³»-½Å°æ, Ç÷°ü(Ç÷¾×) / ü¿Ü-°ñ°Ý, ´« Áõ»ó : ±ÙÀ°º´Áõ, ³· ..
¹«º£Å¸ÁöÁú´Ü¹éÇ÷Áõ(abetalipoproteinemia)  2015.01.02
ÁúȯÁÖ¿äÁ¤º¸ °ü·ÃÁúȯ¸í : Bassen-Kornzweig ÁõÈıº(Bassen-Kornzweig Syndrome) ¿µÇâºÎÀ§ : ü³»-¼ÒÀå, ½Å°æ, ..
¸Æ°üÁö¹æÁ¾(Angiolipoma)  2015.01.02
¥°.°³¿ä Áö¹æÁ¾Àº °¡Àå ÈçÇÑ ¿¬ºÎÁ¶Á÷ Á¾¾çÀ¸·Î ±× Áß 6-17% ¸¦ Â÷ÁöÇÏ´Â ¸Æ°üÁö¹æÁ¾Àº Ç÷°ü°ú Áö¹æ¼¼Æ÷¸¦ Æ÷ÇÔÇÑ ÃµÃµ ..
Ä¿¹Â´ÏƼ - ¿¬¼ö°­Á (9°Ç)
Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15  2024.05.27
Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2024 : 2024-06-15±³À°ÀÏÀÚ : 2024 ..
Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2023 (2ÀÏÂ÷) : 2023-06-17  2023.05.27
Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2023 (2ÀÏÂ÷) : 2023-06-17±³À°ÀÏ ..
Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2023 (1ÀÏÂ÷) : 2023-06-16  2023.05.27
Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Patients with Cardiovascular Disease) 2023 (1ÀÏÂ÷) : 2023-06-16±³À°ÀÏ ..
Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Paients with Cardiovascular Disease) 2022 (2ÀÏÂ÷) : 2022-06-18  2022.05.30
Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Paients with Cardiovascular Disease) 2022 (2ÀÏÂ÷) : 2022-06-18±³À°ÀÏÀÚ ..
Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Paients with Cardiovascular Disease) 2022 (1ÀÏÂ÷) : 2022-06-17  2022.05.30
Ç÷°ü¿µ»ó»ý¸®¿¬±¸È¸ IPOP(Imaging and Physiology on Paients with Cardiovascular Disease) 2022 (1ÀÏÂ÷) : 2022-06-17±³À°ÀÏÀÚ ..
Çѱ¹¿©ÀÚÀÇ»çȸ Achieving optimal Low Density Lipoprotein-Cholesterol(LDL-C) Goal with Ezetimibe and Atorvastatin : 2021-12-02  2021.11.11
Çѱ¹¿©ÀÚÀÇ»çȸ Achieving optimal Low Density Lipoprotein-Cholesterol(LDL-C) Goal with Ezetimibe and Atorvastatin : 2021- ..
´ëÇѽÉÇ÷°üÁßÀçÇÐȸ IPOP 2019 : 2019-06-22  2019.06.05
´ëÇѽÉÇ÷°üÁßÀçÇÐȸ IPOP 2019 : 2019-06-22±³À°ÀÏÀÚ : 2019-06-22±³À°Àå¼Ò : ±¤ÁÖ°úÇбâ¼ú¿ø(GIST) ¿À·æ°ü 1Ãþ ´Ù¸ñ ..
À¥¹®¼­
"IPOÅ°·Î" ¿¡ ´ëÇÑ °Ë»ö °á°ú
ÇÑÀÇ¿ø ¼ºÇü¿Ü°ú Ä¡°ú ¾È°ú ¿©¼ºº´¿ø ³»°ú Á¤Çü¿Ü°ú ÇǺΰú ¼Ò¾Æ°ú À̺ñÀÎÈÄ ºñ´¢/´ëÀå ¿ä¾çº´¿ø ÀçÈ°ÀÇÇÐ µ¿¹°º´¿ø " IPOÅ°
"IPO" ¿¡ ´ëÇÑ °Ë»ö °á°ú
IPO P(Imaging and Physiology on Paients with Cardiovascular Disease) 2022
"±×¸²Àμâ" ¿¡ ´ëÇÑ °Ë»ö °á°ú
¹ÙÀÌ¿À±â¾÷ IPO ±Þ¼ºÀå ¡¦ 4Q 14°³ »óÀå Àü¸Á ¸Þµð´º½º kr »óÀå ¿ÃÄ®¶ó Àμâ 1õ¸Å 170,000¿ø, À§Á¶¹æÁö Àμâ , °¡°ø
´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ENDO 2024 (Day2) : 2024-07-05 ¿¬¼ö°­ÁÂ
Dinis-Ribeiro(IPO Porto) ±³À°½Ã°£ 07¿ù 05ÀÏ ±×·£µåº¼·ë 09:15~09:30 Role of virtual a
¿ùºù °Ç°­½ÄÇ° °í±¸¸¶ °Ç°­Á¤º¸
¿ùºù °Ç°­½ÄÇ° °í±¸¸¶ °í±¸¸¶´Â ÀÙ, ÁÙ±â. »Ñ¸®, Çϳªµµ ¹ö¸± °ÍÀÌ ¾ø´Â °í±¸¸¶! °í±¸¸¶~¸À°ú È¿´ÉÀÌ ¶Ù¾î³³´Ï´Ù ³ë¶û°í±¸¸¶ ÃÖ±Ù ¹Ì±¹°øÀÍ°úÇм¾ÅÍ
"źÇÙ¾È" ¿¡ ´ëÇÑ °Ë»ö °á°ú
ÀûÀý»ç¿ë Áöħ ÃßÁø Çѱ¹º¸°ÇÀǷῬ±¸¿ø(ÀÌÇÏ NECA)Àº Áö³­ 3 ¸Þµð´º½º Á¦¾à¾÷°è µ·ÀÌ ¸ðÀδ٠¡¦ IPO ¿¬ÀÌ¾î ¡®ÈïÇ࡯ Ãßõ: 0
"Ä¡¸Å½Å¾à" ¿¡ ´ëÇÑ °Ë»ö °á°ú
µð¾ØµðÆĸ¶ÅØ IPO ÃßÁø µ¿±¸¹ÙÀÌ¿ÀÁ¦¾àÀº °ü°è»çÀÎ Ä¡¸Å Áúȯ ½Å¾à °³¹ß¾÷ü µð¾ØµðÆĸ¶ÅØÀÌ ±â¾÷°ø°³( Ä¡¸Å ¸¦ ÀÏÀ¸Å°´Â ¾ËÃ÷ÇÏÀ̸Ӻ´
2019³â Á¦10Â÷ Çѱ¹Á¶Á÷°øÇÐÀç»ýÀÇÇÐȸ ±³À°½ÉÆ÷Áö¾ö : 2019-11-22 ¿¬¼ö°­ÁÂ
â¾÷°ú IPO±îÁö À±¿ø¼ö(Çѱ¹»ê¾÷±â¼ú´ë / (ÁÖ)Ƽ¾Ø¾Ë¹ÙÀÌ¿ÀÆÕ) ±³À°½Ã°£ 11-22 1002È£ 17:05~17:40 ¹ÙÀÌ¿Àº¥Ã³ÀÇ ¼º
 
½Ç½Ã°£ Àα⠰˻ö¾î
   ´ºÆ®·º½ºÇÑÀÇ¿ø
   ½ÃÇ÷ϻç½Å
   ºÎ»êħÀß³õ´ÂÇÑÀÇ¿ø
   ¹Ìµå¸²¼ºÇü¿Ü°úÀÇ¿ø
   ÃµÇϵ¿ÀÎÇÑÀÇ¿ø
5
   Á¦¹Ì±Û·Î
1
   ¾ÆÀ̸®½ºÄ¡°ú
1
   Ç×¹®¿Ü°ú
1
   ³ëº§ÀÇ¿ø
1
   È²Áر¸ÅëÁõÀÇÇаúÀÇ¿ø
1
Ä¿¹Â´ÏƼ BEST ´õº¸±â

[Ãæ³²] õ¾Èº»Á¤Çü¿Ü°ú..

[°æ±â] °æÈñ¸¶À½ÀÚ¸®ÇÑ.. [1]

[´ëÀü] ¼¼ÇÏÄ¡°úÀÇ¿ø

[°æ±â] ÇѸ²´ëÇб³¼º½É..

[ºÎ»ê] ±èµ¿ÁøÁ¤½Å°Ç°­..

[ÀÎõ] ¼öÀ̺ñÀÎÈÄ°úÀÇ..

[¼­¿ï] ±è¿µÇåÁ¤½Å°úÀÇ..

[¼­¿ï] ´õ¹Ù¸¥¸¶ÃëÅëÁõ..

[°æ±â] 365¼Ò»ç¹úÁ¾ÇÕÀÇ..

[ºÎ»ê] ¿Â¿ä¾çº´¿ø

°£ÀÌ ¾ÈÁÁÀ» ¶§ ³ªÅ¸³ª.. [2]

öºÐÀÌ ¸¹Àº À½½Ä ¹× ö.. [2]

³úÁ¹Áß ÀüÁ¶ Áõ»ó

¹éÇ÷º´ Ãʱ⿡ ¾î¶² Áõ..

±¸±âÀÚ È¿´É ¹× ±¸±âÀÚ..

[Áúº´°úÄ¡·á¹ý] ±âÄ¡·á,..

±âħÀÌ ½ÉÇÒ¶§, ±âħ¿¡ .. [1]

µÕ±¼·¹Â÷ È¿´É

±Ý¿¬ ÈÄ ½Åüº¯È­ Àå´Ü..

Èæ¿°¼ÒÀÇ È¿´É

¸Þµð¾÷